WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002032427) STABLE ORAL FORMULATION CONTAINING BENZIMIDAZOLE DERIVATIVE
Latest bibliographic data on file with the International Bureau   

Considered void 2002-09-03 00:00:00.0


Pub. No.:    WO/2002/032427    International Application No.:    PCT/BE2000/000126
Publication Date: 25.04.2002 International Filing Date: 20.10.2000
IPC:
A61K 9/20 (2006.01), A61K 9/28 (2006.01), A61K 31/355 (2006.01), A61K 31/44 (2006.01), A61K 31/4439 (2006.01)
Applicants: GALEPHAR M/F [BE/BE]; Rue du Parc Industriel 39, B-6900 Marche-en-Famenne (BE) (For All Designated States Except US).
VANDERBIST, Francis [BE/BE]; (BE) (For US Only).
SERENO, Antonio [BE/BE]; (BE) (For US Only).
BAUDIER, Philippe [BE/BE]; (BE) (For US Only)
Inventors: VANDERBIST, Francis; (BE).
SERENO, Antonio; (BE).
BAUDIER, Philippe; (BE)
Agent: POWIS DE TENBOSSCHE, Roland; Cabinet Bede S.A., Boulevard Lambermont 140, B-1030 Bruxelles (BE)
Priority Data:
Title (EN) STABLE ORAL FORMULATION CONTAINING BENZIMIDAZOLE DERIVATIVE
(FR) FORMULATION STABLE ADMINISTRABLE PAR VOIE ORALE CONTENANT UN DERIVE DE BENZIMIDAZOLE
Abstract: front page image
(EN)An enteric formulation containing at least one benzimidazole derivative, said formulation comprising: a core containing at least one benzimidazole derivative and at least one lipophilic antioxidant, and an enteric envelope protecting the core at least at a pH of 3 to 5, preferably at a pH of 1 to 5.
(FR)La présente invention concerne une formulation entéro-soluble qui contient au moins un dérivé de benzimidazole, cette formulation renfermant: un noyau contenant au moins un dérivé de benzimidazole et au moins un antioxydant lipophile, et une pellicule protectrice entéro-soluble protégeant le noyau ayant un pH qui se situe entre 3 et 5 et qui, de préférence, se situe entre 1 et 5.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)